Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 8, Issue 321, Pages 321ra5-321ra5
Publisher
American Association for the Advancement of Science (AAAS)
Online
2016-01-14
DOI
10.1126/scitranslmed.aab4109
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epidemiology of fragile X syndrome: A systematic review and meta-analysis
- (2014) Jessica Hunter et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Pharmacogenetic Inhibition of eIF4E-Dependent Mmp9 mRNA Translation Reverses Fragile X Syndrome-like Phenotypes
- (2014) Christos G. Gkogkas et al. Cell Reports
- High MMP-9 activity levels in fragile X syndrome are lowered by minocycline
- (2013) Magdalena Dziembowska et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Autism spectrum disorders: The quest for genetic syndromes
- (2013) Dimitrios I. Zafeiriou et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Electrocortical changes associated with minocycline treatment in fragile X syndrome
- (2013) Andrea Schneider et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The translation of translational control by FMRP: therapeutic targets for FXS
- (2013) Jennifer C Darnell et al. NATURE NEUROSCIENCE
- The FMRP regulon: from targets to disease convergence
- (2013) Esperanza Fernández et al. Frontiers in Neuroscience
- Chronic administration of AFQ056/Mavoglurant restores social behaviour in Fmr1 knockout mice
- (2012) Ilse Gantois et al. BEHAVIOURAL BRAIN RESEARCH
- Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome
- (2012) C. A. Hoeffer et al. GENES BRAIN AND BEHAVIOR
- Chronic Pharmacological mGlu5 Inhibition Corrects Fragile X in Adult Mice
- (2012) Aubin Michalon et al. NEURON
- The trouble with spines in fragile X syndrome: density, maturity and plasticity
- (2012) C.X. He et al. NEUROSCIENCE
- Rescue of dendritic spine phenotype in Fmr1 KO mice with the mGluR5 antagonist AFQ056/Mavoglurant
- (2012) Andreea S. Pop et al. PSYCHOPHARMACOLOGY
- AFQ056, a new mGluR5 antagonist for treatment of fragile X syndrome
- (2011) Josien Levenga et al. NEUROBIOLOGY OF DISEASE
- Epigenetic Modification of the FMR1 Gene in Fragile X Syndrome Is Associated with Differential Response to the mGluR5 Antagonist AFQ056
- (2011) S. Jacquemont et al. Science Translational Medicine
- Early continuous inhibition of group 1 mGlu signaling partially rescues dendritic spine abnormalities in the Fmr1 knockout mouse model for fragile X syndrome
- (2010) Tao Su et al. PSYCHOPHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now